Centre Approves IMPCL Disinvestment with Skymap Pharma as Winning Bidder
The Indian government has officially approved the disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), selecting Skymap Pharma as the highest bidder for the acquisition. This strategic move, finalized this week in New Delhi, marks a significant milestone in the Union government’s broader efforts to streamline public sector undertakings and optimize state-owned assets. IMPCL, a…
